These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17487763

  • 1. Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
    Shu J, Ren N, Du JB, Zhang M, Cong HL, Huang TG.
    Scand Cardiovasc J; 2007 Jun; 41(3):149-54. PubMed ID: 17487763
    [Abstract] [Full Text] [Related]

  • 2. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C, Fiotti N, Di Chiara A, Altamura N, Wasserman S, Fioretti P, Guarnieri G.
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
    Robertson L, Grip L, Mattsson Hultén L, Hulthe J, Wiklund O.
    J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
    [Abstract] [Full Text] [Related]

  • 6. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Itaya H, Shiba M, Wada M, Iijima R, Yamamoto M, Yamamoto M, Hara H, Takagi T, Asahara T, Mitsuo K, Kobayashi N, Sugi K.
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [Abstract] [Full Text] [Related]

  • 7. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
    Nomoto K, Oguchi S, Watanabe I, Kushiro T, Kanmatsuse K.
    J Cardiol; 2003 Nov; 42(5):201-6. PubMed ID: 14658408
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
    Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K.
    Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department.
    Ferroni P, Rosa A, Di Franco M, Palmirotta R, Guadagni F, Davì G, Bertazzoni G, Basili S.
    Clin Chim Acta; 2007 Jun; 381(2):151-6. PubMed ID: 17408606
    [Abstract] [Full Text] [Related]

  • 12. Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction.
    Aström-Olsson K, Hedström E, Hultén LM, Wiklund O, Arheden H, Ohlin AK, Gottsäter A, Ohlin H.
    J Invasive Cardiol; 2007 Nov; 19(11):452-6. PubMed ID: 17986718
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
    El Messal M, Beaudeux JL, Drissi A, Giral P, Chater R, Bruckert E, Adlouni A, Chapman MJ.
    Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Mar; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 19. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
    Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.
    Ko YG, Jung JH, Park S, Choi E, Joung B, Hwang KC, Ha JW, Choi D, Jang Y, Chung N, Shim WH, Cho SY.
    Int J Cardiol; 2006 Sep 10; 112(1):66-71. PubMed ID: 16309761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.